Assignee
SHANGHAI PHARMACEUTICALS HOLDING CO LTD
CN·9 granted patents·16 pending applications·3 citations·filing 2016–2023
Top patents by PatentIndex Score
25 records- 0167US11578074B2Nitrogenous heterocyclic compound, preparation method, intermediate, composition, and applicationSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2018·Granted Feb 14, 2023·1 cites·24 claims
- 0266US10828305B2Nitrogenous heterocyclic compound, preparation method, intermediate, composition and useSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2017·Granted Nov 10, 2020·1 cites·17 claims
- 0364US10519150B2Salts of morpholine derivative, crystal forms thereof, processes for producing the same, pharmaceutical compositions including the same, and use thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2016·Granted Dec 31, 2019·1 cites·16 claims
- 0460US10988476B2Substituted pyrimidines as cyclin-dependent kinase inhibitorsSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2020·Granted Apr 27, 2021·0 cites·18 claims
- 0556US10870627B2Salt of quinazoline derivative, preparation method therefor and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2017·Granted Dec 22, 2020·0 cites·12 claims
- 0655US2023398123A1Methods to treat inflammatory bowel diseaseSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 0752US2024317686A1RORyT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOFSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 0851US10662186B2Substituted pyrimidines as cyclin-dependent kinase inhibitorsSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2016·Granted May 26, 2020·0 cites·4 claims
- 0951US2024116925A1Salt of nitrogen-containing fused heterocyclic compound or crystal form thereof, and preparation method therefor, pharmaceutical composition thereof, and use thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2022·Application pending·0 cites
- 1051US2025197424A1Quinoline compound and use thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2023·Application pending·0 cites
- 1151US2024197737A1Application of compound in preparation of inhibitory drug targeting erbb2 mutantSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2022·Application pending·0 cites
- 1251US2023330093A1Application of nitrogen-containing saturated heterocyclic compoundSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 1351US2025163053A1Crystalline form of nitrogen-containing heterocyclic compound, preparation method therefor and use thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2023·Application pending·0 cites
- 1451US2024262793A1Quinazoline compound, and preparation method therefor and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2022·Application pending·0 cites
- 1549US2022380433A1Tmem59 protein dimer or chimeric expression receptor improving t cell functionSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 1648US2023365563A1Quinazoline compound and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 1748US2023028539A1Pharmaceutical composition, complementary kit and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 1847US2022324868A1Pyrazolone-Fused Pyrimidine Compound, and Preparation Method and Use ThereforSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 1946US11643428B2Therapeutic drug for neurodegenerative disease and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2019·Granted May 9, 2023·0 cites·19 claims
- 2046US2024101552A1Carbonyl heterocyclic compound and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 2145US2022259210A1Pyrazolone-Fused Pyrimidine Compound, Preparation Method for Same and Applications ThereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 2245US2022195397A1Immune cell containing tumor antigen recognition receptor and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 2342US2022048915A1Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application ThereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2019·Application pending·0 cites
- 2438US11578092B2Compound for preventing or treating neurodegenerative disease and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2019·Granted Feb 14, 2023·0 cites·11 claims
- 2537US10344035B2Salt of quinolone compound, polymorphs thereof, preparation method therefor, composition, and applicationsSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2016·Granted Jul 9, 2019·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI PHARMACEUTICALS HOLDING CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →